Core-Shell Nanofiber Wound Dressing for Bacterial Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound dressings for detecting bacterial infections are limited by sensitivity and response time, often requiring invasive procedures and delayed treatment, and lack correlation with clinically relevant bacterial concentrations.

Innovation Solution

Development of core-shell nanofibers with a bacterially degradable shell and a core containing an antibacterial agent and biocompatible polymer, which undergoes color change and releases the agent in response to bacterial lipase, enabling early detection and targeted treatment of wound infections.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional wound dressings continuously release antibacterial agents, then antibacterial coverage is maintained, but cytotoxicity increases and healing is delayed

Engineering Contradiction:
Improveantibacterial coverageVSAvoidcytotoxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The wound dressing transitions from static continuous release to dynamic responsive release. The antibacterial agents are encapsulated in nanofibers that remain intact under normal conditions but release their payload dynamically when triggered by bacterial presence, detected through color change indicators. This dynamic behavior ensures agents are released only when needed, reducing cytotoxicity while maintaining reliability.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes the release parameter from continuous constant release to conditional variable release. The release rate and amount are modulated based on bacterial load, with higher release only when bacterial contamination exceeds safe thresholds. This parameter change optimizes the balance between maintaining antibacterial coverage and minimizing harmful cytotoxic effects on healing tissue.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If wound dressings use invasive detection methods like biopsy or swabbing, then bacterial identification is achieved, but patient pain and secondary trauma increase

Engineering Contradiction:
Improvebacterial identificationVSAvoidpatient pain and secondary trauma
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The wound dressing performs self-detection of bacterial contamination without requiring external invasive procedures. The integrated color change indicators within the nanofiber structure automatically respond to bacterial presence, allowing the dressing to monitor its own environment and provide visual feedback to clinicians, eliminating the need for painful swabbing or biopsy procedures.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The wound dressing combines multiple functions into a single non-invasive device: it provides antibacterial protection, detects bacterial contamination, and communicates infection status through color changes. This multi-functionality eliminates the need for separate diagnostic procedures, achieving accurate bacterial identification without patient pain or secondary trauma.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Loss of time

If wound dressings provide early detection of bacterial load, then treatment timing is improved, but detection sensitivity and response time must be increased

Engineering Contradiction:
Improvetreatment delayVSAvoiddetection sensitivity
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The system uses color change indicators as a visual signal for bacterial detection. Different color states correspond to different bacterial load thresholds, enabling early detection before clinical symptoms appear. This visual indicator system provides rapid, sensitive detection that can be immediately interpreted by clinicians, reducing treatment delay without compromising detection precision.

Inventive Principle:
Principle #32Color changes

4Reliability

If antibacterial agents are released before bacterial exposure, then proactive protection is provided, but agent depletion occurs before infection occurs

Engineering Contradiction:
Improveproactive protectionVSAvoidantibacterial agent availability
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The antibacterial agents are pre-positioned within the nanofiber structure in an encapsulated, ready-to-release state. This preliminary preparation allows for rapid deployment when bacteria are detected, providing proactive protection without premature release. The agents remain available until triggered, ensuring both proactive capability and sustained availability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system extracts the antibacterial agents from continuous release and confines them within the nanofiber capsules until needed. This extraction and encapsulation prevents premature depletion by isolating the agents, allowing them to be released in concentrated form only when bacterial detection triggers the release mechanism, thus maintaining both proactive protection and agent availability.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The core-shell nanofiber wound dressings provide rapid and sensitive detection of bacterial infections, allowing for early intervention and preventing tissue damage, while minimizing cytotoxicity and maintaining wound healing efficacy.

Implementation Method 1

incorporating a chromogenic probe that undergoes a color change in response to the bacteria

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Implementation Method 2

The core-shell nanofiber wound dressings provide rapid and sensitive detection of bacterial infections

Methodology Applied
Scientific EffectLipase enzyme activity: Enzyme

Implementation Method 3

a shell surrounding the core comprising a bacterially degradable polymer

Methodology Applied
Scientific EffectBacterial degradation: Decomposition (biological)

Data Source

PatentUS20250177319A1Color-changing antibacterial nanofiber membrane and method
Publication Date: 2025.06.05 UNIVERSITY OF MANITOBA
  • US20250177319A1 patent drawing
  • US20250177319A1 patent drawing
  • US20250177319A1 patent drawing

AI summary

A bacteria-responsive color-changing, core-shell nanofiber, comprising polyurethane (PU), a hemicyanine-based chromogenic probe localized in the core-shell nanofiber near the surface of the shell, polyvinylpyrrolidone (PVP) dopant in the shell, the hemicyanine-based chromogenic probe further comprising a labile ester linkage that is enzymatically cleavable by bacterial lipase released from clinically relevant strains of bacteria including Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA).